Tiankang Biotechnology: Plans to list the animal vaccine business separately on the North Exchange to obtain more resources and support.

Regarding the company's business integration planning, Tiankang Biologicals stated during an institutional research on April 29th that the company's business involves aspects such as feed, pig farming, animal vaccines, and agricultural products, all of which are part of the livestock industry chain and have certain synergies between different business sectors. The technical content of the animal vaccine business is relatively high, requiring high standards for technological innovation and research and development. The company plans to independently list this business on the Northbound Exchange to gain more resource support. The feed and farming businesses are highly relevant, and the integration between these two businesses will continue to increase in the future, possibly achieving integration. The agricultural products business mainly provides raw material support services for the feed business.